Navigation Links
MEDdevice Acquisition Co., LLC Announces Board Members and Advisors
Date:5/14/2008

AURORA, Colo., May 14 /PRNewswire/ -- MEDdevice Acquisition Co., LLC MDAC is proud to announce that it has engaged a highly experienced team with deep domain experience and proven success optimizing investments in the medical device market as board members and advisors.

Board members announced include:

Tony Dimun, CEO of Nascent Enterprises, LLC, formerly of Vital Signs Inc., and Bionx Implants Inc.

Larry Gold, PhD, Chairman and CEO of SomaLogic Inc., and formerly of NeXstar Pharma Inc., Gilead, and the University of Colorado.

Alan West a partner at Pittsburgh Life Sciences Greenhouse, and formerly of Michigan Tech Enterprise Corporation, Boston Scientific, and Vision Sciences Inc.

Advisors announced include:

Frank DeBernardis, CEO of Cascade medical and a partner in Nascent Enterprises, LLC, and formerly with Meadox Medical, and Medtronic.

Sean O'Connell, PhD, currently with the Hospital of Special Surgery and formerly with Novartis, and Robert Wood Johnson Medical School.

J. D. Friedland Managing Director of Epsilon Securities, and formerly with Rothschild Inc., Rinaldini & Co., and Lazard.

Christopher Hazlitt, Esq. of Faegre & Benson LLP.

For more information about MDAC or Epsilon Securities, please contact JD Friedland with Epsilon Securities, LLC directly at 212-242-8844 x.243 or through its website at http://www.epsilonsecurities.com .

About MEDdevice Acquisition Corporation

MEDdevice Acquisition Corporation ("MDAC") was formed by health care industry professionals to acquire and optimize medical product companies and assets. The focus of MDAC is to work with strategic partners to acquire companies or divisions operating in complementary fields, establish management efficiencies and superior market presence to provide significantly enhanced market value in a minimal period of time. For more information on MEDdevice Acquisition Corporation, please visit: http://www.mdacllc.com. MEDdevice Corporation's strategic advisor is JD Friedland with Epsilon Securities, LLC, a specialty M&A advisory firm focused on growing companies in the healthcare sector.

About Catalyst Financial Resources

Catalyst Financial Resources, LLC is an investor awareness firm helping small- and micro-cap companies gain credible exposure in the financial community. Employing the Catalyst System(TM), we augment a firm's existing investor relations activities and assist in achieving appropriate valuation in the marketplace. The Catalyst System(TM) was born out of an intense commitment to the small-cap, under-followed market and the need to forge a new standard on Wall Street. Founded in 2002 by Marc Robins, CFA, Catalyst Financial Resources has a proven track record of meeting the needs of both the management and the shareholders of small-cap companies.

About Epsilon

Epsilon Securities is a specialty advisory firm focused on strategic advisory work to growing companies in the healthcare sector. The company's services include M&A advisory, private placement agency, strategic alliances and valuation work.


'/>"/>
SOURCE MEDdevice Acquisition Co., LLC
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Hearing Scheduled in the Delaware Court of Chancery for August 27, 2007 to Establish the Valid Approval and Consummation of the Merger Between PharmAthene, Inc. and Healthcare Acquisition Corp.
2. Proceedings to Affirm Merger Between PharmAthene and Healthcare Acquisition Corp Initiated in Delaware Chancery Court
3. Drug Royalty Corporation (DRC) Announces Acquisition Regarding PEG-INTRON(R) From Enzon Pharmaceuticals, Inc. (ENZN)
4. NxStage Medical Provides Update on Medisystems Acquisition
5. Palatin Technologies Announces Reacquisition of Full Rights to Bremelanotide Program
6. Validus Pharmaceuticals Expands Product Portfolio with Acquisition of Bipolar Drug: Equetro(R)
7. Federal Trade Commission Clears Kyphons Acquisition of Non-Vertebroplasty Spine-Related Assets of Disc-O-Tech
8. Shanghai Century Acquisition Corporation Announces Sichuan Kelun Pharmaceutical Co Results for the Six Months Ended June 30, 2007
9. Advanced Bio-Technologies Inc Announces Acquisition by HealthEdge Investment Partners, Tampa FL
10. PAREXEL International Completes Acquisition of APEX International Clinical Research Co., Ltd.
11. PAREXEL International Updates Financial Guidance in Conjunction with the Acquisition of APEX International Clinical Research Co., Ltd. and Other Factors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... 2017 Scientists propose in Nature ... in Gaucher and maybe other lysosomal storage diseases as ... than current therapies. An international research team ... which also included investigators from the University of Lübeck ... Feb. 22. The study was conducted in mouse models ...
(Date:2/22/2017)... ... February 22, 2017 , ... LabRoots , ... from around the world, is pleased to announce the 2nd annual Precision Medicine ... This premier, online-only conference focused on the development and advancements in precision medicine. ...
(Date:2/22/2017)... MOINES, Iowa , Feb. 22, 2017 Origin (Origin ... agricultural biotechnology trait and seed provider, and Arcadia ... -based company that develops and commercializes agricultural productivity traits and nutritional ... a key corn biotechnology product developed in China ... of global regulatory trials. ...
(Date:2/22/2017)... ... February 22, 2017 , ... Pharma and biotech ... as European director. Operating from Pennside’s Zurich headquarters, Pennside Partners, GmbH, Mr. Perkins ... Pennside after more than a decade with leading market research firm, GfK. He ...
Breaking Biology Technology:
(Date:2/13/2017)... Feb. 13, 2017  RSA Conference -- RSA, a ... is designed to enhance fraud detection and investigation ... the RSA Fraud & Risk Intelligence Suite. The ... leverage additional insights from internal and external sources ... protect their customers from targeted cybercrime attacks. ...
(Date:2/8/2017)... Feb. 7, 2017  Aware, Inc. (NASDAQ: AWRE ... reported financial results for its quarter and year ended December ... of 2016 was $3.9 million compared to $6.9 million in ... quarter of 2016 was $0.6 million compared to $2.6 million ... fourth quarter of 2016 was $0.5 million, or $0.02 per ...
(Date:2/7/2017)... Zimmer Biomet Holdings, Inc. (NYSE and SIX: ... at the LEERINK Partners 6th Annual Global Healthcare Conference ... February 15, 2017 at 10 a.m. Eastern Time. ... be accessed at http://wsw.com/webcast/leerink28/zbh .  The webcast will ... Biomet,s Investor Relations website at http://investor.zimmerbiomet.com . ...
Breaking Biology News(10 mins):